These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11814620)

  • 1. Neuropeptide Y-induced angiogenesis in aging.
    Kitlinska J; Lee EW; Movafagh S; Pons J; Zukowska Z
    Peptides; 2002 Jan; 23(1):71-7. PubMed ID: 11814620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.
    Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Rose W; Rone J; Movafagh S; Ji H; Yeh Y; Chen WT; Kleinman HK; Grouzmann E; Grant DS
    Circ Res; 1998 Jul; 83(2):187-95. PubMed ID: 9686758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors.
    Movafagh S; Hobson JP; Spiegel S; Kleinman HK; Zukowska Z
    FASEB J; 2006 Sep; 20(11):1924-6. PubMed ID: 16891622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.
    Lee EW; Michalkiewicz M; Kitlinska J; Kalezic I; Switalska H; Yoo P; Sangkharat A; Ji H; Li L; Michalkiewicz T; Ljubisavljevic M; Johansson H; Grant DS; Zukowska Z
    J Clin Invest; 2003 Jun; 111(12):1853-62. PubMed ID: 12813021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Of mice and men: neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability.
    Li L; Najafi AH; Kitlinska JB; Neville R; Laredo J; Epstein SE; Burnett MS; Zukowska Z
    J Cardiovasc Transl Res; 2011 Jun; 4(3):351-62. PubMed ID: 21468772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
    Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
    Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Y2 receptor expression and inhibition of voltage-dependent Ca2+ influx into rod bipolar cell terminals.
    D'Angelo I; Brecha NC
    Neuroscience; 2004; 125(4):1039-49. PubMed ID: 15120863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding.
    Ghersi G; Chen W; Lee EW; Zukowska Z
    Peptides; 2001 Mar; 22(3):453-8. PubMed ID: 11287101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
    Ammar DA; Hughes BA; Thompson DA
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
    Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
    Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing.
    Ekstrand AJ; Cao R; Bjorndahl M; Nystrom S; Jonsson-Rylander AC; Hassani H; Hallberg B; Nordlander M; Cao Y
    Proc Natl Acad Sci U S A; 2003 May; 100(10):6033-8. PubMed ID: 12730369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.
    Fernandez-Sauze S; Delfino C; Mabrouk K; Dussert C; Chinot O; Martin PM; Grisoli F; Ouafik L; Boudouresque F
    Int J Cancer; 2004 Mar; 108(6):797-804. PubMed ID: 14712479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent changes within the intrinsic kidney-associated NPY system and tubular function by litter size reduction.
    Alejandre Alcázar MA; Boehler E; Amann K; Klaffenbach D; Hartner A; Allabauer I; Wagner L; von Hörsten S; Plank C; Dötsch J
    Nephrol Dial Transplant; 2011 Aug; 26(8):2453-65. PubMed ID: 21367848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNAzymes to beta 1 and beta 3 mRNA down-regulate expression of the targeted integrins and inhibit endothelial cell capillary tube formation in fibrin and matrigel.
    Cieslak M; Niewiarowska J; Nawrot M; Koziolkiewicz M; Stec WJ; Cierniewski CS
    J Biol Chem; 2002 Mar; 277(9):6779-87. PubMed ID: 11675378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age.
    Dimitrijević M; Stanojević S; Mitić K; Kustrimović N; Vujić V; Miletić T; Kovacević-Jovanović V
    Peptides; 2008 Dec; 29(12):2179-87. PubMed ID: 18805447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of neuropeptide Y in F344 rat substrains with a reduced dipeptidyl-peptidase IV activity.
    Karl T; Hoffmann T; Pabst R; von Hörsten S
    Pharmacol Biochem Behav; 2003 Jul; 75(4):869-79. PubMed ID: 12957230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice.
    Lee EW; Grant DS; Movafagh S; Zukowska Z
    Peptides; 2003 Jan; 24(1):99-106. PubMed ID: 12576090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent.
    Nilsson T; Lind H; Brunkvall J; Edvinsson L
    Can J Physiol Pharmacol; 2000 Mar; 78(3):251-5. PubMed ID: 10721817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis.
    Carson-Walter EB; Hampton J; Shue E; Geynisman DM; Pillai PK; Sathanoori R; Madden SL; Hamilton RL; Walter KA
    Clin Cancer Res; 2005 Nov; 11(21):7643-50. PubMed ID: 16278383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.